Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LSTA
LSTA logo

LSTA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Lisata Therapeutics Inc (LSTA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
5.010
1 Day change
52 Week Range
5.070
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Lisata Therapeutics Inc (LSTA) is not a strong buy at the moment for a beginner investor with a long-term focus. The lack of positive financial performance, absence of trading signals, and no significant catalysts make it prudent to hold off on investing in this stock right now.

Technical Analysis

The stock's MACD is negatively expanding, suggesting bearish momentum. RSI is neutral at 70.255, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels indicate limited price movement in the short term. Overall, the technical indicators do not strongly support a buy decision.

Positive Catalysts

  • NULL identified. No recent news or significant insider/hedge fund activity.

Neutral/Negative Catalysts

  • Additionally, no recent congress trading data or influential figure activity has been reported.

Financial Performance

In Q4 2025, revenue dropped to $100,000 (-90% YoY), net income dropped to -$2,954,000 (-35.92% YoY), and EPS fell to -0.34 (-38.18% YoY). Gross margin remained flat at 100%. Overall, the financial performance shows significant weakness.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes are available for this stock.

Wall Street analysts forecast LSTA stock price to rise
Analyst Rating
0
Wall Street analysts forecast LSTA stock price to rise
Buy
Hold
Sell
0
Current: 5.010
sliders
Low
0
Averages
0
High
0
0
Current: 5.010
sliders
Low
0
Averages
0
High
0
Brookline
Buy
maintain
$20 -> $32
AI Analysis
2025-07-15
Reason
Brookline
Price Target
$20 -> $32
AI Analysis
2025-07-15
maintain
Buy
Reason
Brookline raised the firm's price target on Lisata Therapeutics to $32 from $20 and keeps a Buy rating on the shares. The firm cites extended patent protection for the target increase after Lisata received a new patent for certepetide through March 2040.

People Also Watch